Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

UBS Group To Pay $15M For Failures In Sale Supervisory

Published 09/29/2016, 10:10 PM
Updated 07/09/2023, 06:31 AM

UBS Financial Services, a wing of UBS Group AG (NYSE:UBS) , has agreed to settle charges of the Securities and Exchange Commission (SEC) related to its supervisory role in selling financial products by paying more than $15 million. Per the regulator, UBS Financial failed to make its sales force trained in selling some complex financial products -- reverse convertible notes (RCNs) -- with the knowledge of their critical aspects.

The UBS unit has agreed to pay disgorgement of $8,227,566 in profits from the sales, along with $798,316 in interest and a $6 million penalty. The company did not admit or deny the charges.

Why the Charges?

RCNs are complex securities that have embedded derivatives whose performance is based on the concept of implied volatility. Lack of adequate training and education made some sales people involve in unsuitable recommendations to certain retail customers.

UBS Financial sold around $548 million of RCNs to more than 8,700 relatively inexperienced retail customers. Many of the customers, including some retirees, were with low-risk tolerance.

Chief of the SEC Enforcement Division’s Complex Financial Instruments Unit – Michael J. Osnato – stated, “When it comes to complex financial products, investors are especially dependent upon firms making sure their financial advisors comprehend the potential risks and rewards of the investments they are recommending. The SEC takes a dim view of firms that fall short in their obligations.”

UBS Group has also been earlier fined with several other lawsuits. In May 2016, the bank agreed to pay more than $500 million to the regulator over allegations of manipulating currency exchange and interest rates. Further, in 2009, UBS Group settled with U.S. authorities for $780 million against charges of helping the U.S. account holders evade taxation.

Shares of UBS declined about 20% over the last year. The stock has seen downward earnings estimate revisions for the current fiscal year over the last 30 days as well, indicating further downside.

However, the following stocks in the foreign bank space with a better estimate revisions trend are worth considering: Itaú Unibanco Holding S.A. (NYSE:ITUB) , Banco Macro S.A. (NYSE:BMA) and The Bank of Nova Scotia (TO:BNS) .

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>



UBS GROUP AG (UBS): Free Stock Analysis Report

BANCO ITAU -ADR (ITUB): Free Stock Analysis Report

BANK OF NOVA SC (BNS): Free Stock Analysis Report

BANCO MACRO-ADR (BMA): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.